Literature DB >> 24847611

Higher prevalence of nephropathy in young Roma females compared with non-Roma females.

Jaroslav Rosenberger, Mária Majerníková, Peter Jarcuska, Daniel Pella, Mária Mareková, Andrea Madarasová Gecková, Monika Halánová.   

Abstract

OBJECTIVES: Ethnic differences in the prevalence of various chronic diseases, including end-stage renal disease, have been previously reported. Surprisingly, data focusing on the lower grade of chronic kidney disease (CKD) are scarce. Thus, the aim of this study was to explore differences in the prevalence of nephropathy between the Roma and non-Roma populations.
METHODS: Data from the cross-sectional population based HepaMeta study conducted in Slovakia were used. Nephropathy was defined as: a known history of any kidney disease; or the presence of proteinuria/hematuria; or glomerular filtration rate (GFR) < 60 ml/min. The odds ratio for the prevalence of nephropathy was calculated using binary logistic regression.
RESULTS: In an age-adjusted model, Roma females had OR of 1.56 for having nephropathy over non-Roma females (OR 1.56; 95% CI 1.01-2.42; p < 0.05). In addition, Roma females had a significantly lower GFR (mean difference 3.4 ml/min, t = -3.58, p < 0.001); all female patients with proteinuria were Roma.
CONCLUSIONS: This cross-sectional study on the young general population found that Roma females have half-higher odds for nephropathy than non-Roma females. Therefore, to prevent risks we should focus on searching for ethnic, social and medical determinants of CKD. Interventions to decrease the incidence of CKD in the target population should also address ethnic inequalities as well as female gender.

Entities:  

Mesh:

Year:  2014        PMID: 24847611     DOI: 10.21101/cejph.a3898

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  7 in total

1.  Kidney diseases in Roma and non-Roma children from eastern Slovakia: are Roma children more at risk?

Authors:  Gabriel Kolvek; Ludmila Podracka; Jaroslav Rosenberger; Roy E Stewart; Jitse P van Dijk; Sijmen A Reijneveld
Journal:  Int J Public Health       Date:  2014-10-01       Impact factor: 3.380

2.  Health-endangering everyday settings and practices in a rural segregated Roma settlement in Slovakia: A descriptive summary from an exploratory longitudinal case study.

Authors:  Andrej Belak; Andrea Madarasova Geckova; Jitse P van Dijk; Sijmen A Reijneveld
Journal:  BMC Public Health       Date:  2017-01-28       Impact factor: 3.295

3.  The Roma Population Living in Segregated Settlements in Eastern Slovakia Has a Higher Prevalence of Metabolic Syndrome, Kidney Disease, Viral Hepatitis B and E, and Some Parasitic Diseases Compared to the Majority Population.

Authors:  Zelmira Macejova; Pavol Kristian; Martin Janicko; Monika Halanova; Sylvia Drazilova; Daniela Antolova; Maria Marekova; Daniel Pella; Andrea Madarasova-Geckova; Peter Jarcuska; HepaMeta Team
Journal:  Int J Environ Res Public Health       Date:  2020-04-29       Impact factor: 3.390

4.  The Survival of Roma Minority Patients on Chronic Hemodialysis Therapy - A Romanian Multicenter Survey.

Authors:  Florica Gadalean; Daniel Lighezan; Dana Stoian; Oana Schiller; Romulus Timar; Bogdan Timar; Flaviu Bob; Mihaela Dora Donciu; Mircea Munteanu; Adelina Mihaescu; Adrian Covic; Adalbert Schiller
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

5.  Roma Housing and Eating in 1775 and 2013: A Comparison.

Authors:  Michal Kozubik; Jitse P van Dijk; Barbora Odraskova
Journal:  Int J Environ Res Public Health       Date:  2018-03-25       Impact factor: 3.390

6.  Toluene abuse markers in marginalized populations.

Authors:  Beáta Hubková; Oliver Rácz; Gabriel Bódy; Eugen Frišman; Mária Mareková
Journal:  Interdiscip Toxicol       Date:  2018-08-06

7.  Roma Ethnicity and Sex-Specific Associations of Serum Uric Acid with Cardiometabolic and Hepatorenal Health Factors in Eastern Slovakian Population: The HepaMeta Study.

Authors:  Maria Pallayova; Marek Brenisin; Alina Putrya; Martin Vrsko; Sylvia Drazilova; Martin Janicko; Maria Marekova; Daniel Pella; Andrea Madarasova Geckova; Peter Urdzik; Peter Jarcuska; HepaMeta Team
Journal:  Int J Environ Res Public Health       Date:  2020-10-21       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.